ISSUES OF ACCESS TO PHARMACEUTICAL PRODUCTS IN THE GEORGIAN PHARMACEUTICAL MARKET

Abstract

The structure of the paper focused on the problem of drug availability in the Georgian pharmaceutical market, the evaluation of the state of health and social policy, the objective and synthesized information, the critical analysis and argumentation of the similar results obtained by field and desk research, allows to make the final conclusion. During the research period, those state campaigns and programs, which are characterized by more opportunities, scope, ease of technical execution, drug quality, wide range of nomenclature, and significant budgeting of prices, were especially successful.

With these characteristics, research results, high level of satisfaction among the population and certain positive indicators of expectations, especially from Turkey, the import in a simplified manner has solved the problem of access to overpriced drugs in the country. A number of noteworthy factors for the stability and improvement of the situation in the future have been identified. For example, increasing the awareness of Form 100, covering more of the chronic program and not only adding generics, stabilizing the prices of Turkish medicines, quality control, increasing the list of RX on referent prices and including the essential and necessary medicines for chronic patients from OTC medicines, in the background of the necessary economic recovery for the country, further support of the government's media and society, and others.